|   LifeSciVC

Biotech IPO Market: Closing The Books On 2018’s Crazy Year

By Bruce Booth, DPhil, Partner

2018 was an incredible boom year in the number of new biotech offerings, with 60 IPOs on US exchanges. But as we’re all painfully aware, after the overall biotech market ($XBI) touched its all-time high in August, the last third of the year was challenging – indices plummeting over 25% in four months.

Read more.